Navigating the Biotech Investment Paradox
The ebook "Navigating the Biotech Investment Paradox" explores how small to midsize biotech companies are outpacing larger competitors through agile technology adoption, rapid innovation, and strategic partnerships, while addressing the challenges of rising valuations and heightened expectations amid resource constraints.
Small to midsize biotechs have been gaining ground on their larger competitors, thanks in part to their nimbler adoption of new technologies, faster paced innovation, and partnerships with larger companies.
With higher valuations comes higher expectations.
In this ebook, you will learn how organizations are making moves to meet these expectations despite the pressure to do more with less resources and experience.
Related
Techstrong TV: AI Leadership Insights for Scientific Research and Drug Discovery
In this Techstrong TV interview, Dotmatics CEO Thomas Swalla discusses how the company leverages AI to accelerate scientific research and drug discovery by streamlining workflows, enabling breakthroughs, and reducing costs in R&D.
Maximize Your Data Impact
The article discusses how R&D leaders can maximize the impact of their data by adopting AI/ML technologies, establishing robust data infrastructures, and leveraging automation and external partnerships, as highlighted by insights from Dotmatics' collaboration with LINUS and their State of Science survey revealing scientists' strategic shifts toward automation and partnerships amid scientific and economic challenges.
MSN: Why Artificial Intelligence Could Help Save the Planet
In an MSN interview, AI executive Emil Eifrem argues that responsible use of artificial intelligence can enhance sustainability, optimize supply chains, and address environmental challenges, exemplified by Dotmatics' application of AI to accelerate drug discovery and improve R&D efficiency while reducing resource use.
Lab Manager: AI in the Lab for Faster, Smarter Drug Discovery
Dotmatics VP of Strategy Christian Olsen explains in a Lab Manager article how AI enhances laboratory workflows by improving data analysis and accelerating decision-making, thereby augmenting research processes and boosting efficiency and innovation in drug discovery without replacing physical experiments.
FAIR Data Principles Explained
The FAIR Data Principles, established in 2016 by a diverse group of stakeholders, provide high-level, non-domain-specific guidelines to make data and metadata Findable, Accessible, Interoperable, and Reusable, thereby enhancing data management for both humans and machines to improve collaboration, efficiency, and value in scientific research and development across disciplines and data types.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.